| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1044313971 |
| P356 | DOI | 10.1038/SJ.GT.3300819 |
| P698 | PubMed publication ID | 10341880 |
| P5875 | ResearchGate publication ID | 12956747 |
| P2093 | author name string | Shimomura K | |
| Kaneda Y | |||
| Tomita N | |||
| Kawamura I | |||
| Manda T | |||
| Tsujimoto S | |||
| Higaki J | |||
| Morishita R | |||
| Ogihara T | |||
| Aketa M | |||
| Kida I | |||
| Lacey E | |||
| Tomoi M | |||
| P2860 | cites work | Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells | Q67995489 |
| Cancer cachexia | Q68149864 | ||
| Manifestations of cancer cachexia induced by colon 26 adenocarcinoma are not fully ascribable to interleukin‐6 | Q71941400 | ||
| Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery | Q72801179 | ||
| Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence | Q24598724 | ||
| Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells | Q24603946 | ||
| A Restriction Point for Control of Normal Animal Cell Proliferation | Q24620882 | ||
| Activation of interleukin-6 gene expression through the NF-kappa B transcription factor | Q28646310 | ||
| Function and activation of NF-kappa B in the immune system | Q29547790 | ||
| E2F: a link between the Rb tumor suppressor protein and viral oncoproteins | Q29618375 | ||
| NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control | Q29620172 | ||
| Structure, regulation and function of NF-kappa B | Q29620225 | ||
| E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor | Q33856709 | ||
| Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model | Q33909897 | ||
| Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group | Q34057488 | ||
| Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides | Q34138108 | ||
| A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo | Q34159206 | ||
| Evidence for the involvement of interleukin 6 in experimental cancer cachexia | Q35602921 | ||
| In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer | Q35762528 | ||
| Functional analysis of the human vascular cell adhesion molecule 1 promoter | Q36232054 | ||
| Identification of a 70-base-pair cell cycle regulatory unit within the promoter of the human thymidine kinase gene and its interaction with cellular factors | Q36689580 | ||
| Regulation of gene expression with double-stranded phosphorothioate oligonucleotides | Q38338297 | ||
| In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction | Q38343941 | ||
| Role of transcriptional cis-elements, angiotensinogen gene-activating elements, of angiotensinogen gene in blood pressure regulation | Q38361254 | ||
| Tumor necrosis factor and cachexia: a current perspective | Q40612161 | ||
| E2F and cell proliferation: a world turned upside down | Q41000774 | ||
| Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication | Q41715223 | ||
| Mesangial cell accessory functions: mediation by intercellular adhesion molecule-1. | Q42475177 | ||
| Cell-cycle control and its watchman. | Q53453500 | ||
| P433 | issue | 1 | |
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | 91-97 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model | |
| P478 | volume | 6 |
| Q38316293 | A decoy oligonucleotide to NF-κB delivered through inhalable particles prevents LPS-induced rat airway inflammation |
| Q37202396 | A role for NF-kappaB-dependent gene transactivation in sunburn. |
| Q41852980 | Cancer cachexia-when proteasomal inhibition is not enough |
| Q35214893 | Catabolic mediators as targets for cancer cachexia |
| Q38304234 | Cell death in NF-kappaB-dependent tumour cell lines as a result of NF-kappaB trapping by linker-modified hairpin decoy oligonucleotide. |
| Q38350156 | Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts |
| Q36560452 | Energy homeostasis and cachexia in chronic kidney disease |
| Q45869627 | Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-kappa B/Rel- specific decoy oligodeoxynucleotides |
| Q35111740 | Expression of NF-kappaB and IkappaB proteins in skeletal muscle of gastric cancer patients |
| Q37515656 | Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer |
| Q81679902 | Hsp70 overexpression inhibits NF-kappaB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy |
| Q38969210 | Immunomodulation of cystic fibrosis epithelial cells via NF-κB decoy oligonucleotide-coated polysaccharide nanoparticles |
| Q53362509 | In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy. |
| Q38337831 | In vivo transfection of a cis element 'decoy' against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity |
| Q34205025 | Inhibiting NF-κB activation by small molecules as a therapeutic strategy |
| Q38299475 | Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice |
| Q38306587 | Local administration of transcription factor decoy oligonucleotides to nuclear factor-kappaB prevents carrageenin-induced inflammation in rat hind paw. |
| Q39174681 | MG132-mediated inhibition of the ubiquitin-proteasome pathway ameliorates cancer cachexia |
| Q54111600 | Modulation of estrogen receptor gene transcription in breast cancer cells by liposome delivered decoy molecules. |
| Q39094397 | Molecular mechanism of sarcopenia and cachexia: recent research advances. |
| Q34171597 | Muscle paralysis and myosin loss in a patient with cancer cachexia |
| Q34731415 | NF-kappa B: arresting a major culprit in cancer |
| Q33744644 | NF-kappaB activation in hypothalamic pro-opiomelanocortin neurons is essential in illness- and leptin-induced anorexia |
| Q34590839 | New drugs for the anorexia-cachexia syndrome |
| Q73150593 | Not a minute to waste |
| Q38316449 | Nuclear factor-kappaB decoy oligodeoxynucleotides attenuates ischemia/reperfusion injury in rat liver graft |
| Q37803214 | Oligonucleotide delivery in cancer therapy |
| Q36039925 | Osteolytic bone diseases: physiological analogues of bone resorption effectors as alternative therapeutic tools |
| Q35862864 | Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties |
| Q36052673 | Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents. |
| Q45889179 | Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model |
| Q37019253 | Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting. |
| Q36028202 | Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass |
| Q92810873 | Serum amyloid A1 mediates myotube atrophy via Toll-like receptors |
| Q38686236 | Skeletal muscle atrophy: disease-induced mechanisms may mask disuse atrophy |
| Q33993411 | The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in mice |
| Q34102964 | The role of NF-kappaB/IkappaB proteins in cancer: implications for novel treatment strategies |
| Q38363836 | The sensitivity of MCF10A breast epithelial cells to alkylating drugs is enhanced by the inhibition of O6-methylguanine-DNA methyltransferase transcription with a synthetic double strand DNA oligonucleotide. |
| Q34078075 | Therapeutic applications of transcription factor decoy oligonucleotides |
| Q39616150 | Transfection of NF-κB decoy oligodeoxynucleotide suppresses pulmonary metastasis by murine osteosarcoma |
Search more.